Caption
Stem Cell Research
Targeting different brain cells could be an option for new Parkinson’s treatments
Date
News
Date
Researchers at King’s College London are starting a world-first clinical trial to test if a probiotic drink could help with motor and non-motor symptoms of Parkinson's.
Date
A clinical trial has produced further evidence that there is no benefit of delaying levodopa therapy.
Date
We’re investing a further £1.5million to advance pioneering drug discovery work to develop new molecules that can both improve symptoms and slow progression.
Date
European study suggests that smoking has a protective role to reduce the risk of developing Parkinson's.
Date
A US study has found that people with Attention-Deficit Hyperactivity Disorder (ADHD) may have an increased risk of developing Parkinson's.
Date
Researchers in Israel have made positive steps towards a simple diagnostic test for Parkinson's.
Date
Researchers in America have developed an experimental drug, similar to compounds used to treat diabetes, that slows the progression of Parkinson's in a mouse model of the condition.
Date
Researchers have discovered that nicotinamide riboside, a form of vitamin B3, may boost energy in nerve cells and help prevent them being lost in Parkinson's.
Date
Further analysis of the results from a recent clinical trial of the type 2 diabetes drug exenatide in people with Parkinson's has revealed encouraging signs of a positive effect on mood.
Date
The trial will test whether drug treatment with a commonly prescribed dementia drug can improve balance and walking and help to prevent falls in people with Parkinson's.